140 related articles for article (PubMed ID: 8204360)
1. Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19.
Mantovani LT; Miotti S; Ménard S; Canevari S; Raspagliesi F; Bottini C; Bottero F; Colnaghi MI
Eur J Cancer; 1994; 30A(3):363-9. PubMed ID: 8204360
[TBL] [Abstract][Full Text] [Related]
2. Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivo.
Bottero F; Tomassetti A; Canevari S; Miotti S; Ménard S; Colnaghi MI
Cancer Res; 1993 Dec; 53(23):5791-6. PubMed ID: 8242637
[TBL] [Abstract][Full Text] [Related]
3. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
4. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein.
Coney LR; Tomassetti A; Carayannopoulos L; Frasca V; Kamen BA; Colnaghi MI; Zurawski VR
Cancer Res; 1991 Nov; 51(22):6125-32. PubMed ID: 1840502
[TBL] [Abstract][Full Text] [Related]
5. Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography.
Li PY; Del Vecchio S; Fonti R; Carriero MV; Potena MI; Botti G; Miotti S; Lastoria S; Menard S; Colnaghi MI; Salvatore M
J Nucl Med; 1996 Apr; 37(4):665-72. PubMed ID: 8691264
[TBL] [Abstract][Full Text] [Related]
6. A folate binding protein in ascitic fluid, serum and ovarian tissue of patients with ovarian adenocarcinoma immunoreacts with antibodies against human milk folate binding protein.
Holm J; Hansen SI; Høier-Madsen M; Helkjaer PE
Biosci Rep; 1998 Apr; 18(2):49-57. PubMed ID: 9743473
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.
Miotti S; Canevari S; Ménard S; Mezzanzanica D; Porro G; Pupa SM; Regazzoni M; Tagliabue E; Colnaghi MI
Int J Cancer; 1987 Mar; 39(3):297-303. PubMed ID: 2434438
[TBL] [Abstract][Full Text] [Related]
8. Role of membrane folate-binding protein in the cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cell lines in vitro.
Sen S; Erba E; D'Incalci M; Bottero F; Canevari S; Tomassetti A
Br J Cancer; 1996 Feb; 73(4):525-30. PubMed ID: 8595169
[TBL] [Abstract][Full Text] [Related]
9. Isolation and biochemical characterization of the soluble and membrane forms of folate binding protein expressed in the ovarian carcinoma cell line IGROV1.
Tomassetti A; Coney LR; Canevari S; Miotti S; Facheris P; Zurawski VR; Colnaghi MI
FEBS Lett; 1993 Feb; 317(1-2):143-6. PubMed ID: 8428622
[TBL] [Abstract][Full Text] [Related]
10. Unidirectional potentiation of binding between two anti-FBP MAbs: evaluation of the involved mechanisms.
Casalini P; Mezzanzanica D; Valota O; Adobati E; Tomassetti A; Colnaghi MI; Canevari S
J Cell Biochem; 1995 May; 58(1):47-55. PubMed ID: 7642722
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of folate binding protein in ovarian cancers.
Toffoli G; Cernigoi C; Russo A; Gallo A; Bagnoli M; Boiocchi M
Int J Cancer; 1997 Apr; 74(2):193-8. PubMed ID: 9133455
[TBL] [Abstract][Full Text] [Related]
12. Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivo.
Miotti S; Facheris P; Tomassetti A; Bottero F; Bottini C; Ottone F; Colnaghi MI; Bunni MA; Priest DG; Canevari S
Int J Cancer; 1995 Nov; 63(3):395-401. PubMed ID: 7591238
[TBL] [Abstract][Full Text] [Related]
13. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman SD; Lark RH; Coney LR; Fort DW; Frasca V; Zurawski VR; Kamen BA
Cancer Res; 1992 Jun; 52(12):3396-401. PubMed ID: 1596899
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells.
Corona G; Toffoli G; Fabris M; Viel A; Zarrelli A; Donada C; Boiocchi M
Eur J Cancer; 1997 Jul; 33(8):1284-90. PubMed ID: 9301457
[TBL] [Abstract][Full Text] [Related]
15. Relationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines.
Ottone F; Miotti S; Bottini C; Bagnoli M; Perego P; Colnaghi MI; Ménard S
Br J Cancer; 1997; 76(1):77-82. PubMed ID: 9218736
[TBL] [Abstract][Full Text] [Related]
16. Network of idiotypic and anti-idiotypic antibodies related to the ovarian carcinoma-associated folate binding protein.
Pupa SM; Bazzini P; Menard S; Colnaghi MI
Anticancer Res; 1992; 12(5):1565-70. PubMed ID: 1332580
[TBL] [Abstract][Full Text] [Related]
17. Distribution of OV-TL 3 and MOv18 in normal and malignant ovarian tissue.
Buist MR; Molthoff CF; Kenemans P; Meijer CJ
J Clin Pathol; 1995 Jul; 48(7):631-6. PubMed ID: 7560169
[TBL] [Abstract][Full Text] [Related]
18. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells.
Corona G; Giannini F; Fabris M; Toffoli G; Boiocchi M
Int J Cancer; 1998 Jan; 75(1):125-33. PubMed ID: 9426700
[TBL] [Abstract][Full Text] [Related]
19. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity.
Holm J; Hansen SI; Høier-Madsen M; Birn H; Helkjaer PE
Arch Biochem Biophys; 1999 Jun; 366(2):183-91. PubMed ID: 10356282
[TBL] [Abstract][Full Text] [Related]
20. Soluble intercellular adhesion molecule-1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenografts.
Giavazzi R; Nicoletti MI; Chirivi RG; Hemingway I; Bernasconi S; Allavena P; Gearing AJ
Eur J Cancer; 1994; 30A(12):1865-70. PubMed ID: 7880619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
